Form D — SRT Therapeutics, Inc.
0002080322-25-000008 · filed Aug 14, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $47,510,731
- Total sold
- $47,399,588
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- SRT Therapeutics, Inc.
- CIK
- 2080322
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 5601 Oberlin Drive, Suite 100
San Diego, CA 92121 - Phone
- (858) 868-7108
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Lauren Otsuki · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Ed Prunchunas · DirectorSan Diego, CA Find on LinkedIn ↗
-
Shierley Widjaja · DirectorSan Diego, CA Find on LinkedIn ↗
-
Michael Walsh · DirectorSan Diego, CA Find on LinkedIn ↗
-
Rolf Benirschke · DirectorSan Diego, CA Find on LinkedIn ↗
-
Brian G. Feagan, M.D. · DirectorSan Diego, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗